Summit Therapeutics Inc. (SMMT) Insider Trading
Healthcare · Pharmaceutical Preparations
Open-market and disclosed Form 4 insider trading for Summit Therapeutics Inc. (SMMT) on InvestAtlant.
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-06-12 | Zanganeh Mahkam | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $49.99M |
| 2026-06-12 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $49.99M |
| 2026-06-04 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | .46M |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO, Director | Purchase | $360.8K |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO, Director | Purchase | $361.5K |
| 2026-06-04 | Zanganeh Mahkam | Co-Chief Executive Officer, Director, 10% Owner | Purchase | .46M |
| 2025-10-21 | Xia Yu | Director | Purchase | 0.00M |
| 2025-10-21 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $500.0K |